Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1981 Jan;45(1):42–47. doi: 10.1136/hrt.45.1.42

Reappraisal of lignocaine therapy in management of myocardial infarction.

B L Pentecost, J V De Giovanni, P Lamb, P J Cadigan, K L Evemy, E J Flint
PMCID: PMC482487  PMID: 7459164

Abstract

The use of lignocaine in the prevention of ventricular fibrillation among patients admitted to a coronary care unit has been reviewed over the 12-year period 1967 to 1978 inclusive. The practice of suppressing warning ventricular ectopic activity has gradually been abandoned with the result that whereas in 1967 to 1968 33 per cent of all patients received lignocaine therapy, in 1972 to 1973 the number had fallen to 15 per cent, and in 1977 to 1978 to 4 per cent. The incidence of ventricular fibrillation was not significantly changed at 9.1, 7.7, and 7.8 per cent, respectively. Approximately 80 per cent of all patients suffering ventricular fibrillation within the coronary care unit were initially resuscitated and approximately 50 per cent survived hospital admission. Death was rarely a result of recurrent ventricular fibrillation and for the most part took the form of pump failure or late unexpected death. Experience suggests that the use of lignocaine to suppress ventricular ectopic activity observed in the first few hours of admission to hospital with acute myocardial infarction has no therapeutic value.

Full text

PDF
42

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman E. L., Kerber R. E., Harrison D. C. Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques. Am J Cardiol. 1974 Sep;34(3):342–349. doi: 10.1016/0002-9149(74)90037-x. [DOI] [PubMed] [Google Scholar]
  2. Bennett M. A., Pentecost B. L. Warning of cardiac arrest due to ventricular fibrillation and tachycardia. Lancet. 1972 Jun 24;1(7765):1351–1352. doi: 10.1016/s0140-6736(72)91090-2. [DOI] [PubMed] [Google Scholar]
  3. Bennett M. A., Wilner J. M., Pentecost B. L. Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet. 1970 Oct 31;2(7679):909–911. doi: 10.1016/s0140-6736(70)92073-8. [DOI] [PubMed] [Google Scholar]
  4. Chopra M. P., Thadani U., Portal R. W., Aber C. P. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial. Br Med J. 1971 Sep 18;3(5776):668–670. doi: 10.1136/bmj.3.5776.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Conley M. J., McNeer J. F., Lee K. L., Wagner G. S., Rosati R. A. Cardiac arrest complicating acute myocardial infarction: predictability and prognosis. Am J Cardiol. 1977 Jan;39(1):7–12. doi: 10.1016/s0002-9149(77)80003-9. [DOI] [PubMed] [Google Scholar]
  6. Darby S., Cruickshank J. C., Bennett M. A., Pentecost B. L. Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet. 1972 Apr 15;1(7755):817–819. doi: 10.1016/s0140-6736(72)90801-x. [DOI] [PubMed] [Google Scholar]
  7. Dhurandhar R. W., MacMillan R. L., Brown K. W. Primary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol. 1971 Apr;27(4):347–351. doi: 10.1016/0002-9149(71)90429-2. [DOI] [PubMed] [Google Scholar]
  8. Gamble O. W., Cohn K. Effect of propranolol, procainamide, and lidocaine on ventricular automaticity and reentry in experimental myocardial infarction. Circulation. 1972 Sep;46(3):498–506. doi: 10.1161/01.cir.46.3.498. [DOI] [PubMed] [Google Scholar]
  9. Gianelly R., von der Groeben J. O., Spivack A. P., Harrison D. C. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med. 1967 Dec 7;277(23):1215–1219. doi: 10.1056/NEJM196712072772301. [DOI] [PubMed] [Google Scholar]
  10. Harrison D. C. Should lidocaine be administered routinely to all patients after acute myocardial infarction? Circulation. 1978 Oct;58(4):581–584. doi: 10.1161/01.cir.58.4.581. [DOI] [PubMed] [Google Scholar]
  11. Lie K. I., Wellens H. J., Downar E., Durrer D. Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation. 1975 Nov;52(5):755–759. doi: 10.1161/01.cir.52.5.755. [DOI] [PubMed] [Google Scholar]
  12. Lie K. I., Wellens H. J., van Capelle F. J., Durrer D. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. N Engl J Med. 1974 Dec 19;291(25):1324–1326. doi: 10.1056/NEJM197412192912504. [DOI] [PubMed] [Google Scholar]
  13. Lown B., Fakhro A. M., Hood W. B., Jr, Thorn G. W. The coronary care unit. New perspectives and directions. JAMA. 1967 Jan 16;199(3):188–198. [PubMed] [Google Scholar]
  14. Lown B., Vassaux C. Lidocaine in acute myocardial infarction. Am Heart J. 1968 Oct;76(4):586–587. doi: 10.1016/0002-8703(68)90148-8. [DOI] [PubMed] [Google Scholar]
  15. Nevins M. A. Letter: Lidocaine and heart rate. Circulation. 1975 May;51(5):951–951. [PubMed] [Google Scholar]
  16. Noneman J. W., Rogers J. F. Lidocaine prophylaxis in acute myocardial infarction. Medicine (Baltimore) 1978 Nov;57(6):501–515. doi: 10.1097/00005792-197811000-00002. [DOI] [PubMed] [Google Scholar]
  17. Prescott L. F., Adjepon-Yamoah K. K., Talbot R. G. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure. Br Med J. 1976 Apr 17;1(6015):939–941. doi: 10.1136/bmj.1.6015.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Spracklen F. H., Kimerling J. J., Besterman E. M., Litchfield J. W. Use of lignocaine in treatment of cardiac arrhythmias. Br Med J. 1968 Jan 13;1(5584):89–91. doi: 10.1136/bmj.1.5584.89. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES